BENZODIAZEPINE DERIVATIVES

Rilmazafone .HCL

Rilmazafone (リスミー,, previously known as 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effect

$ 16.80

Deschloroclotizolam

Deschloroclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017. This product is intended for laborato

$ 19.20

FLUCLOTIZOLAM

Fluclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017. This product is intended for laboratory rese

$ 19.80

Nitromethaqualone

Nitromethaqualone is an kind of methaqualone that has similar sedative and hypnotic properties. It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg. However, the aromatic nitro group is metabolise

$ 5.20

Methylmethaqualone

Methylmethaqualone (MMQ) is a quinazolinone and an kind of methaqualone that has similar sedative and hypnotic properties to its parent compound (resulting from its agonist activity at the β subtype of the GABAA receptor), and is around the same potency.

$ 5.20

FLUBROMAZEPAM

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug. It is a structural

$ 11.00

Deschloroetizolam

Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated of the closely related to etizolam. The compound has been sold as a designer drug… This product is intended for laboratory research purposes only and are

$ 11.20

PYRAZOLAM

Pyrazolam (SH-I-04)is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently "rediscovered" and sold as a designer drug starting in 2012. Pyrazolam has structural similarities t

$ 19.00

Sl-164

SL-164 is methaqualone developed in the late 1960s by a team at Sumitomo. SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use. This product is intended for laboratory resear

$ 2.50

BROMAZOLAM

BROMAZOLAM is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, it was never FDA approved and was never available to the public. This product is intended for laboratory research purposes only

$ 10.00

3-HYDROXYPHENAZEPAM

3-HYDROXYPHENAZEPAM is a benzodiazepine with hypnotic, sedative, anxiolytic, and anticonvulsant properties, Relative to phenazepam, 3-hydroxyphenazepam has diminished myorelaxant properties, but is about equivalent in most other regards.Like other benzodi

$ 9.00